These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 206836)

  • 21. A bladder tumor model response to immunotherapy.
    deKernion JB; Ramming KP; Fraser K
    Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
    Yuhas JM; Ullrich RL
    Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
    Vanhaelen CP; Fisher RI
    Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
    Bast RC; Berek JS; Obrist R; Griffiths CT; Berkowitz RS; Hacker NF; Parker L; Lagasse LD; Knapp RC
    Cancer Res; 1983 Mar; 43(3):1395-401. PubMed ID: 6825108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of rat fibrosarcoma by radiotherapy plus immune adjuvant.
    Moroson H; Schechter M
    Biomedicine; 1976 May; 25(3):97-100. PubMed ID: 949523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
    Ullrich RL; Adams LM
    Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1202-8. PubMed ID: 148948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
    Suit HD; Sedlacek R; Silobrcic V
    Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
    Castro JE; Sadler TE; Jones PD
    Dev Biol Stand; 1977 Apr 13-15; 38():277-81. PubMed ID: 608510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Corynebacterium parvum and chronic Toxoplasma infection on metastatic brain tumors in mice.
    Conley FK
    J Natl Cancer Inst; 1979 Nov; 63(5):1237-44. PubMed ID: 291750
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of C. parvum on growth and induction of intracerebral tumours in mice.
    Osborn DE; Sadler TE; Castro JE
    Br J Cancer; 1977 Apr; 35(4):420-5. PubMed ID: 857825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging in an experimental model of brain tumor immunotherapy.
    Blankenberg F; Conley FK; Sayre J; Enzmann D
    AJNR Am J Neuroradiol; 1991; 12(3):543-8. PubMed ID: 2058511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intracerebrally injected Corynebacterium parvum on the development and growth of metastatic brain tumor in mice.
    Kennedy JD; Sutton RC; Conley FK
    Neurosurgery; 1989 Nov; 25(5):709-14. PubMed ID: 2586725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma.
    Woodruff MF; Hitchcock E; Whitehead VL
    Br J Cancer; 1977 May; 35(5):687-92. PubMed ID: 861152
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
    Scott MT
    J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
    Fisher B; Wolmark N; Saffer E; Fisher ER
    Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.